4 completed, 2 recruiting, 2 unknown, 1 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 4, Recruiting 2, Unknown 2, Terminated 1 |
Follow Sleep Apnea, Central: new trials by email Literature Review of Sleep Apnea, Central trials Research Report on Sleep Apnea, Central
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment Trazodone + positive airway pressure (PAP) therapy, Oxygen + positive airway pressure (PAP) therapy - Sleep Disordered Breathing, Able Bodied | Phase 4 | Recruiting | VA Office of Research and Development | 200 | 2026-09-16 | 2026-10-13 |
| Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude Naltrexone Pill, Placebo - Altitude, Sleep Apnea, Central | Phase 4 | Completed | VA Loma Linda Health Care System | 16 | 2021-08-08 | 2023-04-26 |
| Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment Acetazolamide + supplemental oxygen + PAP therapy, Zolpidem + PAP therapy, Buspirone + PAP therapy - Sleep Disordered Breathing, Able Bodied | Phase 4 | Recruiting | VA Office of Research and Development | 200 | 2021-01-07 | 2026-07-20 |
| Sleep and Breathing in the General Population - Chemical Stimuli Zolpidem, No Treatment - Sleep-disordered Breathing | Phase 4 | Completed | Wayne State University | 14 | 2018-07-03 | 2023-12-06 |
| Nocturnal Oxygen Needs and Central Sleep Apnea in Patients With Chronic Heart Failure. Titration of nocturnal oxygen needs to prevent desaturations - Chronic Heart Failure, Central Sleep Apnea | Phase 4 | Unknown | Laval University | 14 | 2018-04-15 | 2022-04-08 |
| Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome Medical Air vs Oxygen - Sleep Apnea, Central, Prader-Willi Syndrome | Phase 4 | Completed | The Hospital for Sick Children | 9 | 2016-09-01 | 2025-06-08 |
| Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance Zopiclone, Placebo - Sleep Apnea, Central, Ventricular Dysfunction | Phase 4 | Terminated | University Hospital, Grenoble | 2 | 2016-05-01 | 2021-05-26 |
| Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption Acetazolamide-placebo, Placebo-acetazolamide - Central Sleep Apnea, Secondary | Phase 4 | Unknown | Shahid Beheshti University of Medical Sciences | 12 | 2014-11-01 | 2018-05-08 |
| Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF CRT + AOP - Heart Failure, Central Sleep Apnea | Phase 4 | Completed | Medtronic Cardiac Rhythm and Heart Failure | 44 | 2005-06-01 | 2025-07-03 |
Sleep Apnea Syndromes (4) · Heart Failure (3) · Cheyne-Stokes Respiration (1) · Creatine deficiency, X-linked (1) · Opium Dependence (1) · Prader-Willi Syndrome (1) · Ventricular Dysfunction (1)
Apnea (9) · Dyssomnias (9) · Nervous System Diseases (9) · Respiration Disorders (9) · Respiratory Tract Diseases (9) · Sleep Disorders, Intrinsic (9) · Sleep Wake Disorders (9) · Sleep Apnea Syndromes (5) · Cardiovascular Diseases (4) · Heart Diseases (4) · Abnormalities, Multiple (1) · Chemically-Induced Disorders (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Zolpidem (2) · Acetazolamide (1) · Buspirone (1) · Naltrexone (1) · Oxygen (1) · Therapeutics (1) · Trazodone (1) · zopiclone (1)
VA Office of Research and Development (2) · Laval University (1) · Medtronic Cardiac Rhythm and Heart Failure (1) · Shahid Beheshti University of Medical Sciences (1) · The Hospital for Sick Children (1) · University Hospital, Grenoble (1) · VA Loma Linda Health Care System (1) · Wayne State University (1)
United States (4) · Canada (2) · France (1) · Germany (1) · Iran (1)
M Safwan Badr, MD (2) · James D Anholm, MD (1) · M Safwan Badr, MD, MBA (1) · Moein Forughi, MD (1) · Parisa Adimi, MD (1) · Reshma Amin, MD (1) · S Andreas, Prof. Dr (1)
PMID 31808012, PMID 35286569, PMID 38966963
I01CX001944 (1), I01RD001576 (1), R01HL130552 (1)